 5. Patients who are currently receiving chronic 14 days treatment with corticosteroids at a dose equal to or more than 10 mg of prednisone or its glucocorticoid equivalent per day, or any other chronic immunosuppressive treatment that cannot be discontinued prior to starting study drug 